Insulet’s (PODD) Outperform Rating Reiterated at Raymond James
Insulet (NASDAQ:PODD – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Raymond James in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $328.00 target price on the medical instruments supplier’s stock, up from their previous target price of $294.00. Raymond James’ price […]
Insulet (NASDAQ:PODD – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Raymond James in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $328.00 target price on the medical instruments supplier’s stock, up from their previous target price of $294.00. Raymond James’ price […]
